Strong Revenue Growth
Quest Diagnostics reported a 15.2% increase in consolidated revenues, with a 5.2% organic revenue growth and diagnostic information services revenues up by 15.7%.
Increased Earnings Per Share
Adjusted EPS grew by 11.5% to $2.62, compared to $2.35 the prior year, reflecting strong top-line growth and productivity gains.
Successful Acquisitions
Acquisitions contributed significantly to growth, with a notable 20% revenue growth in the physician channel and an 8% contribution to M&A growth from LifeLabs.
Operational Improvements
Quest continues to target 3% annual cost savings through its Invigorate program, with automation and AI technologies being deployed to improve quality and productivity.
Increased Cash Flow
Cash from operations increased by 67.1% year-over-year to $858 million, driven by higher operating income and a one-time CARES Act tax credit.
Raised Full-Year Guidance
Quest Diagnostics raised its full-year 2025 revenue guidance to between $10.8 billion and $10.92 billion, with adjusted EPS expected to be in a range of $9.63 to $9.83.